Skip to main content

Pathstone Holdings, LLC

Position in MRK — Merck & Co., Inc.

CIK 2011612 ENGLEWOOD, NJ

Position in MRK

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$57,815,583
+$8,387,594 QoQ
Shares Held
480,635
+2.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 29.43335379237883.ToString("F0")% Shared 0.5790256639653791.ToString("F0")% None 69.9876205436558.ToString("F0")%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2025
CallValue
$15,832
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $479,605,626 across 16 Drug Manufacturers - General names. MRK ranks #3 (12.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 MRK
Merck & Co., Inc.
This page
480,635 $57,815,583

All Filings in MRK

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $57,815,583 480,635
2025-12-31 $49,427,989 469,580
2025-09-30 $39,077,134 465,592
2025-06-30 $15,832 200
2025-06-30 $36,621,473 462,626
2025-03-31 $43,922,708 489,335
2024-12-31 $51,755,364 520,259
2024-09-30 $59,996,586 528,325
2024-06-30 $66,280,538 535,384
2024-03-31 $71,613,091 542,729
2023-12-31 $57,207,044 524,739